We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $95.5B
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
+24.25%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$64.3B
AUM Growth
+$9.38B
Cap. Flow
-$1.88B
Cap. Flow %
-2.92%
Top 10 Hldgs %
13.59%
Holding
699
New
57
Increased
192
Reduced
352
Closed
81

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$357M
2
ABBV icon
AbbVie
ABBV
+$264M
3
ALSN icon
Allison Transmission
ALSN
+$258M
4
AMGN icon
Amgen
AMGN
+$220M
5
GS icon
Goldman Sachs
GS
+$210M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$282M
2
PFE icon
Pfizer
PFE
+$259M
3
MRK icon
Merck
MRK
+$245M
4
KMB icon
Kimberly-Clark
KMB
+$229M
5
FE icon
FirstEnergy
FE
+$209M

Sector Composition

Rank Sector Weight
1 Financials 21.93%
2 Industrials 15.47%
3 Healthcare 15.43%
4 Technology 13.03%
5 Consumer Discretionary 12.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LHX icon
126
L3Harris
LHX
$56.5B
$165M 0.26%
872,758
-246,251
-22% -$45.1M
PCAR icon
127
PACCAR
PCAR
$70.2B
$164M 0.26%
2,855,924
+31,718
+1% +$1.86M
ENS icon
128
EnerSys
ENS
$6.94B
$164M 0.25%
1,969,328
-307,697
-14% -$24.1M
EQR icon
129
Equity Residential
EQR
$25.2B
$163M 0.25%
2,741,385
+471,900
+21% +$26.7M
NGVT icon
130
Ingevity
NGVT
$2.59B
$162M 0.25%
2,137,181
-19,798
-0.9% -$1.29M
JAZZ icon
131
Jazz Pharmaceuticals
JAZZ
$16B
$161M 0.25%
977,426
+2,824
+0.3% +$421K
HP icon
132
Helmerich & Payne
HP
$3.36B
$161M 0.25%
+6,939,190
New +$134M
CHX
133
DELISTED
ChampionX
CHX
$160M 0.25%
10,462,303
-2,122,823
-17% -$23.6M
ESNT icon
134
Essent Group
ESNT
$6.12B
$158M 0.25%
3,662,119
+369,251
+11% +$16M
GNTX icon
135
Gentex
GNTX
$4.88B
$156M 0.24%
4,601,552
-42,535
-0.9% -$1.31M
TRV icon
136
Travelers Companies
TRV
$81.4B
$155M 0.24%
1,101,569
+12,336
+1% +$1.58M
AUY
137
DELISTED
Yamana Gold, Inc.
AUY
$153M 0.24%
26,797,460
-15,893,258
-37% -$89.4M
KSU
138
DELISTED
Kansas City Southern
KSU
$152M 0.24%
745,565
-842,580
-53% -$158M
EXPE icon
139
Expedia Group
EXPE
$33.4B
$152M 0.24%
1,144,345
+15,565
+1% +$1.75M
NEM icon
140
Newmont
NEM
$98.5B
$151M 0.24%
2,529,291
-496,509
-16% -$30.6M
CNQ icon
141
Canadian Natural Resources
CNQ
$93.4B
$151M 0.24%
12,852,319
+8,944,039
+229% +$89.9M
RGA icon
142
Reinsurance Group of America
RGA
$15.7B
$150M 0.23%
1,292,452
-1,182,986
-48% -$132M
ICLR icon
143
Icon
ICLR
$13B
$150M 0.23%
768,114
-128,446
-14% -$25.1M
ULTA icon
144
Ulta Beauty
ULTA
$20.7B
$148M 0.23%
516,109
+181,684
+54% +$46M
WRK
145
DELISTED
WestRock Company
WRK
$148M 0.23%
+3,399,123
New +$140M
EVTC icon
146
Evertec
EVTC
$1.88B
$148M 0.23%
3,754,633
-8,064
-0.2% -$300K
DOX icon
147
Amdocs
DOX
$5.64B
$146M 0.23%
2,054,358
+254,709
+14% +$16M
MRK icon
148
Merck
MRK
$323B
$143M 0.22%
1,835,749
-3,204,698
-64% -$245M
ROST icon
149
Ross Stores
ROST
$78.1B
$142M 0.22%
1,158,413
+218,740
+23% +$22.9M
EXP icon
150
Eagle Materials
EXP
$6.69B
$141M 0.22%
1,387,948
+14,696
+1% +$1.37M

Similar funds

Boston Partners's Q4 2020 Portfolio in Review

As of Q4 2020, Boston Partners held 699 positions worth $64.3B, up 17% from $54.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Boston Partners's Q4 2020 filing shows 57 new, 192 increased, 352 reduced and 81 closed positions. Its largest new stake was Boeing: 1,856,421 shares worth $397M. The largest sale was JPMorgan Chase, an estimated $282M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 21% a quarter earlier, followed by Industrials and Healthcare.

  • Boston Partners's largest Q4 2020 buy was Boeing: 1,856,421 shares worth $397M.
  • Boston Partners added most to AbbVie in Q4 2020, an estimated $264M increase.
  • Boston Partners's biggest Q4 2020 reduction was JPMorgan Chase, cutting an estimated $282M.
  • Boston Partners fully exited Kimberly-Clark in Q4 2020, selling an estimated $229M.
  • Boston Partners's ten largest holdings make up 14% of its $64.3B portfolio in Q4 2020.
  • Boston Partners opened 57 new positions and closed 81 in Q4 2020.
  • Boston Partners's portfolio value rose 17% quarter-over-quarter to $64.3B.

Based on Boston Partners's 13F filing for Q4 2020, filed 4 Feb 2021.